美国FDA更新膳食补充剂上市前安全通告指导意见草案

放大字体缩小字体时间?016-08-12 11:46 来源:食品伙伴网
核心提示:据美国食品药品管理局消息??1日美国FDA发布消息,更新膳食补充剂上市前安全通告指导意见草案。相关通告有助FDA在产品被售出之前识别安全隐患、/div>
食品伙伴网讯 据美国食品药?a href='//www.sqrdapp.com/news/tag_4604.html' class='zdbq' title='管理相关食品资讯' target='_blank'>管理局消息??1日美囼a href='//www.sqrdapp.com/news/tag_12.html' class='zdbq' title='FDA相关食品资讯' target='_blank'>FDA发布消息,更?a href='//www.sqrdapp.com/news/tag_1594.html' class='zdbq' title='膳食补充剂相关食品资? target='_blank'>膳食补充剁/a>上市前安全通告指导意见草案。相关通告有助FDA在产品被售出之前识别安全隐患
按照膳食补充剂健康教育法案的要求,生产商或者经销商需要在含新原料膳食补充剂上市前?5天前向FDA汇报,该新原料已被用于食品无风险的情况除外。如果含有非食品原料并且未在销售的75天前向FDA汇报,那么会被判为掺假、/div>
部分原文报道如下9/div>
The U.S. Food and Drug Administration today issued a revised draft guidance to improve dietary supplement companies' new dietary ingredient (NDI premarket safety notifications to the agency. These notifications help the agency identify safety co ncerns before products reach consumers.
Under the Dietary Supplement Health and Education Act (DSHEA), the manufacturer or distributor must notify the FDA at least 75 days before beginning to market a dietary supplement that co ntains a new dietary ingredient (one that was not marketed in the United States before Oct. 15, 1994), unless the NDI is used in the food supply without chemical alteration. Dietary supplements are co nsidered adulterated if they co ntain an NDI not used in the food supply and the required notification has not been submitted to the FDA 75 days before marketing.
原文链接9/div>
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm516197.htm
日期9a href="//www.sqrdapp.com/news/2016-08-12.html">2016-08-12
[ 食品资讯搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]


推荐图文
食品伙伴网资讯部 电话?535-2122172 传真?535-2129828 邮箱:news@www.sqrdapp.com QQ: 点击这里给我发消? title=
鲁公网安 37060202000128叶/a>
Baidu
map